Drugmaker Corona Remedies Ltd. debuted at a premium on the stock market today, underscoring demand for new stocks among domestic investors. A 40% surge in Corona Remedies’ share price gave the company a market capitalisation of nearly ₹9,000 crore. (HT) After listing at 36.72% premium, Corona Remedies share price rose as much as 41.14% over […]
